HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Luxshare Precision Industry (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Crealights Technology (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Anker Innovations Technology (A/H Listing) - The "Shallow-Sea Theory" Does Not Work Well

Pre-IPO SG Micro Corp (A/H Listing) - Some Points Worth the Attention

Pre-IPO Qdama International Holding - The Business Model Is Not Sustainable

Equity Capital Markets

<ul>
<li>The explosive growth in licensing service revenue, the significant increase in gross margin, and the narrowing of adjusted losses have verified that MOMENTA's business model possesses the ability for self-optimization</li>
<li>Core risks are high customer concentration, self-research/substitution by automakers, high R&amp;D investment.Compared with competitors, MOMENTA has advantages in mass production/global layout, but has weaknesses in hardware/software integration and self-developed chips.</li>
<li>MOMENTA, as a pure software solution provider, is expected to have a valuation lower than that of Huawei's vehicle business unit but higher than that of ordinary SaaS companies.</li>
</ul>


The explosive growth in licensing service revenue, the significant increase in gross margin, and the narrowing of adjusted losses have verified that MOMENTA's business model possesses the ability for self-optimization
Core risks are high customer concentration, self-research/substitution by automakers, high R&amp;D investment.Compared with competitors, MOMENTA has advantages in mass production/global layout, but has weaknesses in hardware/software integration and self-developed chips.
MOMENTA, as a pure software solution provider, is expected to have a valuation lower than that of Huawei's vehicle business unit but higher than that of ordinary SaaS companies.


Pre-IPO Momenta Global (PHIP Updates) - Some Points Worth the Attention